Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy

被引:103
作者
Ho, Chao-Chi [1 ,2 ,3 ]
Kuo, Sung-Hsin [2 ,4 ]
Huang, Pei-Hsin [2 ,5 ]
Huang, Hsin-Yi [2 ,5 ]
Yang, Chih-Hsin [2 ,4 ]
Yang, Pan-Chyr [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan
关键词
caveolin-1; lung cancer; drug resistance; prognosis; pathology; survival;
D O I
10.1016/j.lungcan.2007.07.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Caveolin-1 was up-regulated in different drug-resistant cancer cell tines and was suggested to confer drug resistance by different mechanisms. However, the relation of caveolin-1 expression and the clinical response to chemotherapy and prognosis in non-small cell lung cancer (NSCLC) remains unknown. Total 73 NSCLC (stages IIIB and IV) patients who received gemcitabine-based chemotherapy and also had tumour specimens available before treatment were assessed for caveolin-1 expression using immunohistochemistry. Immunoreactivity of caveolin-1 was correlated with the response to chemotherapy, the clinicopathologic features, and the progression-free survival (PFS) and overall survival (OS) of all patients. Positive caveolin-1 immunostaining was found in 12 (16.4%) of the 73 patients. Eight of the twelve had disease progression and the other four patients remained stable after chemotherapy. Patients with caveolin-1 expression had a significantly lower response rate (complete or partial response, 0% versus 37.7%; P=0.01) and a poor PFS and OS (median survival time: PFS, 4.6 months versus 6.1 months, P=0.005; OS, 7.0 months versus 14 months, P < 0.001) than those without caveolin-1 expression. Moreover, multivariate analyses indicated that caveolin-1 positivity was an independent prognostic factor for disease-free survival (DFS) (P=0.003) and CS (P=0.008), respectively. Caveolin-1 expression significantly correlated with drug resistance and a poor prognosis in advanced NSCLC patients treated with gemcitabine-based chemotherapy. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 39 条
[1]   Cell biology - A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains [J].
Anderson, RGW ;
Jacobson, K .
SCIENCE, 2002, 296 (5574) :1821-1825
[2]   Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene [J].
Bélanger, MM ;
Roussel, E ;
Couet, J .
CHEST, 2004, 125 (05) :106S-106S
[3]   Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells [J].
Bélanger, MM ;
Roussel, É ;
Couet, J .
ANTI-CANCER DRUGS, 2003, 14 (04) :281-287
[4]   Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol [J].
Bist, A ;
Fielding, PE ;
Fielding, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) :10693-10698
[5]  
Davidson B, 2002, AM J CLIN PATHOL, V117, P225
[6]   Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo - A role for the caveolin-scaffolding domain [J].
Engelman, JA ;
Chu, C ;
Lin, A ;
Jo, H ;
Ikezu, T ;
Okamoto, T ;
Kohtz, DS ;
Lisanti, MP .
FEBS LETTERS, 1998, 428 (03) :205-211
[7]   Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth [J].
Engelman, JA ;
Wykoff, CC ;
Yasuhara, S ;
Song, KS ;
Okamoto, T ;
Lisanti, MP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) :16374-16381
[8]   Intracellular cholesterol transport in synchronized human skin fibroblasts [J].
Fielding, CJ ;
Bist, A ;
Fielding, PE .
BIOCHEMISTRY, 1999, 38 (08) :2506-2513
[9]   Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers [J].
Fielding, CJ ;
Bist, A ;
Fielding, PE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3753-3758
[10]  
Fielding CJ, 1997, J LIPID RES, V38, P1503